A Case of Malignant Myxofibrosarcoma With Hypoglycemia Attacks.
blood glucose
hypoglycemia attacks
insulin
insuline-like growth factors
malignant myxofibrosarcoma
myofibroblastic tumor
postoperative radiotherapy
targeted therapy
tru-cut biopsy
wide surgical resection
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
accepted:
01
05
2023
medline:
2
6
2023
pubmed:
2
6
2023
entrez:
2
6
2023
Statut:
epublish
Résumé
Myxofibrosarcoma is a malignant mesenchymal tumor and a fibroblastic sarcoma of the elderly. Myxofibrosarcoma can be low-grade or high-grade depending on the cell characteristics. Wide surgical resection with or without radiotherapy and chemotherapy is the basis of its treatment. Sometimes, tumor cells secrete insulin or insulin-like substances and cause hypoglycemia attacks. Here, we intend to demonstrate the role of early surgery to end hypoglycemia attacks and prevent recurrence and metastases. We also intend to show the insufficiency of tru-cut biopsy to distinguish between low- and high-grade myxofibrosarcoma. An 82-year-old male patient visited our clinic with a rapidly growing giant mass in the left retroscapular area and suffered from hypoglycemic attacks several times a day. After imaging and initial biopsy, the tumor grade was indeterminate on histopathological examination; hence, the mass was removed surgically. The pathological examination resulted in high-grade myxofibrosarcoma whereas the initial biopsy could not elaborate on the grade. The hypoglycemia attacks ceased after the surgery. Adjuvant local radiotherapy at a total dose of 60 Gy was administered in 30 fractions to the surgery area with no complications after the surgery. No new mass, recurrence, or hypoglycemia attack was detected in the three-year follow-up. In conclusion, hypoglycemia attacks may be a marker of malignant tumor presence and may be a clue at the beginning and in the follow-up period both for recurrence and the aggressiveness of the tumoral mass. Because a biopsy may show the diagnosis but not the grade of the tumor, early surgical intervention is needed.
Identifiants
pubmed: 37265904
doi: 10.7759/cureus.38387
pmc: PMC10231523
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e38387Informations de copyright
Copyright © 2023, Afacan et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Surg Oncol Clin N Am. 2016 Oct;25(4):775-88
pubmed: 27591498
Acta Endocrinol (Buchar). 2022 Apr-Jun;18(2):232-237
pubmed: 36212255
Cancer. 2002 Apr 15;94(8):2256-64
pubmed: 12001125
Case Rep Oncol. 2016 Jan 14;9(1):39-44
pubmed: 26933417
J Pathol. 2009 Mar;217(4):469-82
pubmed: 19148905
Am J Dermatopathol. 2003 Aug;25(4):281-6
pubmed: 12876484
Ann Endocrinol (Paris). 2019 Feb;80(1):21-25
pubmed: 29555080
Ann Thorac Surg. 2013 Oct;96(4):1223-1228
pubmed: 23891404